No Detail Found!

Evaluation of Hematological blood tests among COVID-19 patients with chronic disease history

Author(s)
Haitham MH Qutob Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences - Rabigh, King Abdulaziz University, Jeddah, 25732, Saudi Arabia; Medical Laboratory Sciences Department, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia
Abstract
We aimed to appraise the relationship between hematological laboratory tests and the severity of COVID-19 in patients with pre-existing chronic diseases to predict the disease severity. This case-control retrospective study was conducted at Dr. Soliman Fakeeh Hospital, Jeddah, Saudi Arabia, from April to August 2020. Laboratory blood test data of 270 patients with confirmed COVID-19 and admitted to the hospital were enrolled in the study. On the other hand, patients with a respiratory infection, newly diagnosed with a chronic disease, and patients on an anticoagulant were excluded. Patients with no history of chronic disease were grouped into a control group, while the case group included patients with chronic disease. The variances between groups were analyzed by unpaired t-test, while within the groups was paired t-test using SPSS version 19. COVID-19 patients with comorbidities had a higher risk of severe and critical COVID-19 clinical manifestations. Red blood cell and lymphocyte counts were significantly different between the groups at admission (P = 0.012 and 0.027, respectively). Additionally, D-dimer and C-reactive protein (CRP) levels were higher in the comorbid COVID-19 group (64% and 60%, respectively) than in the non-comorbid COVID-19 group. Severe reduction in lymphocyte count and elevation in D-dimer and CRP levels could be potential indicators of COVID-19 severity. These indicators might be helpful in managing patients with chronic diseases.
Publication Details
Page(s) 2040-2047
DOI DOI not available
Published Journal: Bioscience Research, Volume: 19, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
COVID-19, Chronic disease, D-dimer, Covid-19, laboratory biomarkers
0

Citations

0

Downloads

31

Views